Takeda Pharmaceutical Company Limited (TKDA) — Financial Flexibility Index
Takeda Pharmaceutical Company Limited (TKDA) has a Financial Flexibility Index of 0.08x as of December 2025. Free cash flow of €595.62 Billion (operating CF €373.25 Billion minus capex €222.37 Billion) represents 0% of total liabilities (€7.76 Trillion). Check Takeda Pharmaceutical Company Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Takeda Pharmaceutical Company Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Takeda Pharmaceutical Company Limited across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Takeda Pharmaceutical Company Limited.
Annual Financial Flexibility Index for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Takeda Pharmaceutical Company Limited. Explore TKDA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | €1.44 Trillion | €1.06 Trillion | €7.31 Trillion | ▲ +28.6% |
| 2024 | 0.15x | €1.20 Trillion | €716.34 Billion | €7.83 Trillion | ▼ -27.9% |
| 2023 | 0.21x | €1.61 Trillion | €977.16 Billion | €7.60 Trillion | ▲ +27.4% |
| 2022 | 0.17x | €1.25 Trillion | €1.12 Trillion | €7.49 Trillion | ▲ +14.6% |
| 2021 | 0.15x | €1.12 Trillion | €1.01 Trillion | €7.74 Trillion | ▲ +47.4% |
| 2020 | 0.10x | €796.83 Billion | €669.75 Billion | €8.09 Trillion | ▲ +111.1% |
| 2019 | 0.05x | €406.16 Billion | €328.48 Billion | €8.71 Trillion | ▼ -78.1% |
| 2018 | 0.21x | €444.86 Billion | €377.85 Billion | €2.09 Trillion | ▲ +58.7% |
| 2017 | 0.13x | €323.02 Billion | €261.36 Billion | €2.41 Trillion | — |